- Home
- HSHP vs ARCT Comparison
HSHP vs ARCT Comparison
Compare HSHP & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSHP
- ARCT
- Stock Information
- Founded
- HSHP 2021
- ARCT 2013
- Country
- HSHP Bermuda
- ARCT United States
- Employees
- HSHP N/A
- ARCT N/A
- Industry
- HSHP
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- HSHP
- ARCT Health Care
- Exchange
- HSHP Nasdaq
- ARCT Nasdaq
- Market Cap
- HSHP 268.6M
- ARCT 320.8M
- IPO Year
- HSHP 2023
- ARCT N/A
- Fundamental
- Price
- HSHP $7.92
- ARCT $16.76
- Analyst Decision
- HSHP
- ARCT Strong Buy
- Analyst Count
- HSHP 0
- ARCT 10
- Target Price
- HSHP N/A
- ARCT $50.88
- AVG Volume (30 Days)
- HSHP 98.7K
- ARCT 739.3K
- Earning Date
- HSHP 08-08-2025
- ARCT 08-11-2025
- Dividend Yield
- HSHP 5.33%
- ARCT N/A
- EPS Growth
- HSHP N/A
- ARCT N/A
- EPS
- HSHP 0.14
- ARCT N/A
- Revenue
- HSHP $120,680,000.00
- ARCT $122,122,000.00
- Revenue This Year
- HSHP $7.10
- ARCT N/A
- Revenue Next Year
- HSHP $26.34
- ARCT $31.09
- P/E Ratio
- HSHP $58.38
- ARCT N/A
- Revenue Growth
- HSHP 44.77
- ARCT N/A
- 52 Week Low
- HSHP $4.29
- ARCT $8.04
- 52 Week High
- HSHP $8.74
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- HSHP 65.98
- ARCT 54.04
- Support Level
- HSHP $7.49
- ARCT $16.65
- Resistance Level
- HSHP $7.71
- ARCT $17.70
- Average True Range (ATR)
- HSHP 0.14
- ARCT 1.06
- MACD
- HSHP 0.00
- ARCT -0.18
- Stochastic Oscillator
- HSHP 94.12
- ARCT 16.30
About HSHP Himalaya Shipping Ltd.
Himalaya Shipping Ltd is an independent dry bulk company that focuses on owning and operating its Newcastlemax dry bulk carriers.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.